This isn't a restaurant, this is an investment. And when things aren't going smoothly, investors have every right to be concerned, and also they have every right to share those concerns on discussion boards like this.
I'm not sorry you don't like it. Grow up.
When there are zero complaints from where I sit, I won't make any. I've cheered as loud as anyone when we submitted the IDE. Yes, we appear to be closer to submission of IDE than ever, and highest chances of approval as well. I want approval and subsequent successful human clinical trials as much or more than anyone here.
With such few people working at the company...wouldn't it seem prudent to you that 100% of the focus should be on IDE? Instead, they are splitting their time with IsoPet veterinary clinics.
You may think this is a good thing. I do not. It will take longer to get IDE submittal if they don't have 100% of the people working on IDE approval 100% of the time. I want IDE submission/approval ASAP.
Perhaps you don't understand my perspective. That is fine. The last 2 weeks the share price was moving up on no news and low volume. Many were cheering for a run...it never happened and now the inevitable price drop is happening as the last IDE announcement was vague and proved that RDGL once again miscalculated IDE submission requirements and timeline. They never mentioned 8 meetings and also mentioned minimal impact to schedule.
Their lack of focus on IDE is apparent to me. This isn't bashing...it is complaining.
The sooner they focus on what matters and resolve the FDA concerns with the IDE, the sooner I will be much happier with this investment. Just frustrating to know they are not laser focused on IDE.
Market Data 
Markets 
AI
